---
title: "Yihai Kerry (Fuyu) Biotech Raises Registered Capital by About 33% to RMB 2.56 Billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291647718.md"
description: "Yihai Kerry (Fuyu) Biotechnology Co., Ltd. increased its registered capital to RMB 2.56 billion from RMB 1.925 billion, a rise of about 33%, according to 36Kr. The company was established in April 2018 and is legally represented by Chen Xuesong. Its business scope includes grain purchasing, grain and oil storage services, grain sales, and feed raw material sales. It is wholly owned by Yihai Kerry Arawana Holdings Co., Ltd."
datetime: "2026-07-03T09:17:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291647718.md)
  - [en](https://longbridge.com/en/news/291647718.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291647718.md)
generator: "portal-rs"
---

# Yihai Kerry (Fuyu) Biotech Raises Registered Capital by About 33% to RMB 2.56 Billion

Yihai Kerry (Fuyu) Biotechnology Co., Ltd. increased its registered capital to RMB 2.56 billion from RMB 1.925 billion, a rise of about 33%, according to 36Kr. The company was established in April 2018 and is legally represented by Chen Xuesong. Its business scope includes grain purchasing, grain and oil storage services, grain sales, and feed raw material sales. It is wholly owned by Yihai Kerry Arawana Holdings Co., Ltd.

### Related Stocks

- [300999.CN](https://longbridge.com/en/quote/300999.CN.md)
- [KRKR.US](https://longbridge.com/en/quote/KRKR.US.md)

## Related News & Research

- [Pure Hedge - Livestock and Grain](https://longbridge.com/en/news/297700533.md)
- [Grain Spreads: Funds Add Length Again](https://longbridge.com/en/news/297700948.md)
- [ImmunoGenesis Announces Appointment of Reza Mazhari and Mike Davis to Its Board of Directors](https://longbridge.com/en/news/298472601.md)
- [US Plains HRW Wheat-Basis steady as futures ease](https://longbridge.com/en/news/298510561.md)
- [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**